Allient Reports First Quarter 2025 Results, Highlights Strong Sequential Growth in Sales, Margins, and Earnings
-
Revenue was
with gross margin at$132.8 million 32.2% despite lower year-over-year revenue; Higher volume and favorable mix sequentially drove gross margin expansion of 70 basis points compared with fourth quarter of 2024 -
Simplify to Accelerate NOW actions supported a 130 basis point sequential improvement in operating margin, reaching
6.6% -
Diluted earnings per share (EPS) were
, with adjusted EPS of$0.21 $0.46 -
Total orders increased
17% sequentially, resulting in a book-to-bill ratio of 1.04 -
Operating cash flow was
, up$13.9 million 52% , and ended the quarter with of cash; Debt, net of cash, was reduced by$47.8 million during the quarter to$13.6 million $174.4 million - The Company’s leverage ratio was 2.91 at quarter end, as described in the reconciliation of non-GAAP financial measures
Dick Warzala, Chairman and CEO, commented, “Our first quarter results demonstrate the strength of our diversified business model and the effectiveness of our strategic initiatives. We achieved solid sequential growth in sales and profitability overall as we continue to more closely align our business with our customers and focus on taking the necessary actions to ensure we achieve our long-term strategic goals and objectives. Our 'Simplify to Accelerate NOW' actions are aligned with our strategy and are delivering meaningful improvements to our operational performance and positioning us for long-term success.
“We are closely monitoring the evolving trade environment, including recent tariff developments. Additionally, our team is focused on mitigating the impact of the emerging and changing rare earth mineral trade constraints which is introducing new complexities for manufacturers. While these factors present challenges, we remain committed to agility and resilience in our operations. Our focus on innovation, efficiency, and customer value continues to guide us as we adapt to the changing landscape and strive to deliver sustained value to our stakeholders.”
First Quarter 2025 Results (Narrative compares with prior-year period unless otherwise noted)
Revenue decreased
Market Performance:
-
Aerospace & Defense revenue increased
25% , primarily driven by the timing of key defense and space program deliveries. - Medical market revenue remained flat, as solid demand for surgical instruments and improved sales in medical mobility solutions were offset by softness in pump-related products.
-
Vehicle market sales declined
34% , largely attributable to reduced demand for powersports. -
Industrial market revenue decreased
10% . Strength in power quality sales, particularly to the HVAC/data center market, was more than offset by lower demand in industrial automation due to inventory destocking by the Company’s largest customer. -
Distribution channel sales, while representing a smaller portion of total revenue, rose
21% , reflecting broader demand for the Company’s diversified product offerings.
Gross margin for the first quarter was
70 basis points, reflecting the positive impact of higher volume and a favorable product mix.
Operating costs and expenses totaled
Operating income was
The effective income tax rate was
Net income was
Earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, acquisition and integration-related costs, restructuring and business realignment costs, and foreign currency gains/losses (“Adjusted EBITDA”) was
Balance Sheet and Cash Flow Review
Cash and cash equivalents increased
Capital expenditures were
Total debt of
Orders and Backlog Summary ($ in thousands)
Q1 2025 |
Q4 2024 |
Q3 2024 |
Q2 2024 |
Q1 2024 |
|||||||||||
Orders |
$ |
137,622 |
$ |
117,900 |
$ |
102,631 |
$ |
137,373 |
$ |
122,127 |
|||||
Backlog |
$ |
237,323 |
$ |
230,788 |
$ |
238,492 |
$ |
259,002 |
$ |
258,130 |
First quarter orders increased
Backlog grew
Conference Call and Webcast
The Company will host a conference call and webcast on Thursday, May 8, 2025, at 10:00 am ET.
During the conference call, management will review the financial and operating results and discuss Allient’s corporate strategy and outlook. A question-and-answer session will follow.
To listen to the live call, dial (412) 634-6879. In addition, the webcast and slide presentation may be found at: www.allient.com/investors.
A telephonic replay will be available from 2:00 pm ET on the day of the call through Thursday, May 22, 2025.
To listen to the archived call, dial (412) 317-6671 and enter replay pin number 10198077 or access the webcast replay via the Company’s website. A transcript will also be posted to the website once available.
About Allient Inc.
Allient (Nasdaq: ALNT) is a global engineering and manufacturing enterprise that develops solutions to drive the future of market-moving industries, including medical, life sciences, aerospace and defense, industrial automation, robotics, semi-conductor, transportation, agriculture, construction and facility infrastructure. A family of globally responsible companies, Allient takes a One-Team approach to “Connect What Matters” and provides the most robust, reliable, and high-value products and systems by utilizing its core Motion, Controls, and Power technologies and platforms.
Headquartered in
Safe Harbor Statement
The statements in this news release that relate to future plans, events or performance are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements. Examples of forward-looking statements include, among others, statements the Company makes regarding expected savings from restructuring and simplifying actions, the cost of implementing such actions, operating results, expectations for the level of sales, the Company’s belief that it has sufficient liquidity to fund its business operations, and expectations with respect to the conversion of backlog to sales. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of the Company’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, general economic and business conditions, conditions affecting the industries served by the Company and its subsidiaries, conditions affecting the Company's customers and suppliers, competitor responses to the Company's products and services, the overall market acceptance of such products and services, the pace of bookings relative to shipments, the ability to expand into new markets and geographic regions, the success in acquiring new business, the impact of changes in income tax rates or policies, commercial activity and demand across our and our customers’ businesses, global supply chains, the prices of our securities and the achievement of our strategic objectives, the ability to attract and retain qualified personnel, the ability to successfully integrate an acquired business into our business model without substantial costs, delays, or problems, and other factors disclosed in the Company's periodic reports filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict the occurrence of those matters or the manner in which they may affect us. The Company has no obligation or intent to release publicly any revisions to any forward looking statements, whether as a result of new information, future events, or otherwise.
FINANCIAL TABLES FOLLOW
ALLIENT INC. |
|||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
|||||
(In thousands, except per share data) |
|||||
(Unaudited) |
|||||
For the three months ended |
|||||
March 31, |
|||||
2025 |
|
2024 |
|||
Revenue |
$ |
132,803 |
$ |
146,713 |
|
Cost of goods sold |
|
90,051 |
|
99,336 |
|
Gross profit |
|
42,752 |
|
47,377 |
|
Operating costs and expenses: |
|||||
Selling |
|
6,014 |
|
6,298 |
|
General and administrative |
|
13,813 |
|
14,440 |
|
Engineering and development |
|
9,554 |
|
11,067 |
|
Acquisition and integration-related costs |
|
— |
|
326 |
|
Restructuring and business realignment costs |
|
1,499 |
|
|
31 |
Amortization of intangible assets |
|
3,093 |
|
3,115 |
|
Total operating costs and expenses |
|
33,973 |
|
35,277 |
|
Operating income |
|
8,779 |
|
12,100 |
|
Other expense, net: |
|||||
Interest expense |
|
3,635 |
|
3,388 |
|
Other expense (income), net |
|
684 |
|
(109) |
|
Total other expense, net |
|
4,319 |
|
3,279 |
|
Income before income taxes |
|
4,460 |
|
8,821 |
|
Income tax provision |
|
(903) |
|
(1,919) |
|
Net income |
$ |
3,557 |
$ |
6,902 |
|
Basic earnings per share: |
|||||
Earnings per share |
$ |
0.21 |
$ |
0.42 |
|
Basic weighted average common shares |
|
16,599 |
|
16,394 |
|
Diluted earnings per share: |
|||||
Earnings per share |
$ |
0.21 |
$ |
0.42 |
|
Diluted weighted average common shares |
|
16,638 |
|
16,497 |
ALLIENT INC. |
||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||
(In thousands, except per share data) |
||||||
March 31, |
December 31, |
|||||
|
2025 |
|
2024 |
|||
Assets |
||||||
Current assets: |
||||||
Cash and cash equivalents |
$ |
47,753 |
$ |
36,102 |
||
Trade receivables, net of provision for credit losses of |
88,136 |
78,774 |
||||
Inventories |
|
105,571 |
|
111,517 |
||
Prepaid expenses and other assets |
|
12,413 |
|
11,187 |
||
Total current assets |
|
253,873 |
|
237,580 |
||
Property, plant, and equipment, net |
|
64,467 |
|
65,685 |
||
Deferred income taxes |
|
8,771 |
|
9,116 |
||
Intangible assets, net |
|
96,741 |
|
99,671 |
||
Goodwill |
|
132,359 |
|
131,789 |
||
Operating lease assets |
23,445 |
23,748 |
||||
Other long-term assets |
|
7,243 |
|
8,192 |
||
Total Assets |
$ |
586,899 |
$ |
575,781 |
||
Liabilities and Stockholders’ Equity |
||||||
Current liabilities: |
||||||
Accounts payable |
$ |
30,646 |
$ |
27,156 |
||
Accrued liabilities |
|
32,428 |
|
30,221 |
||
Total current liabilities |
|
63,074 |
|
57,377 |
||
Long-term debt |
|
222,202 |
|
224,177 |
||
Deferred income taxes |
|
3,408 |
|
3,642 |
||
Pension and post-retirement obligations |
|
1,597 |
|
1,667 |
||
Operating lease liabilities |
19,070 |
19,417 |
||||
Other long-term liabilities |
|
4,720 |
4,647 |
|||
Total liabilities |
|
314,071 |
|
310,927 |
||
Stockholders’ Equity: |
||||||
Common stock, no par value, authorized 50,000 shares; 16,975 and 16,810 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively |
|
112,722 |
|
111,024 |
||
Preferred stock, par value no shares issued or outstanding |
|
— |
|
— |
||
Retained earnings |
|
180,052 |
|
177,013 |
||
Accumulated other comprehensive loss |
|
(19,946) |
|
(23,183) |
||
Total stockholders’ equity |
|
272,828 |
|
264,854 |
||
Total Liabilities and Stockholders’ Equity |
$ |
586,899 |
$ |
575,781 |
ALLIENT INC. |
|||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||
(In thousands) |
|||||
(Unaudited) |
|||||
For the three months ended |
|||||
March 31, |
|||||
2025 |
|
2024 |
|||
Cash Flows From Operating Activities: |
|||||
Net income |
$ |
3,557 |
$ |
6,902 |
|
Adjustments to reconcile net income to net cash provided by operating activities |
|||||
Depreciation and amortization |
|
6,281 |
|
6,385 |
|
Deferred income taxes |
|
49 |
|
297 |
|
Stock-based compensation expense |
920 |
1,211 |
|||
Debt issue cost amortization recorded in interest expense |
161 |
156 |
|||
Other |
|
1,039 |
|
411 |
|
Changes in operating assets and liabilities, net of acquisitions: |
|||||
Trade receivables |
|
(8,415) |
|
(292) |
|
Inventories |
|
6,511 |
|
(119) |
|
Prepaid expenses and other assets |
|
(1,024) |
|
(1,236) |
|
Accounts payable |
|
2,863 |
|
(2,022) |
|
Accrued liabilities |
|
1,986 |
|
(2,514) |
|
Net cash provided by operating activities |
|
13,928 |
|
9,179 |
|
Cash Flows From Investing Activities: |
|||||
Consideration paid for acquisitions, net of cash acquired |
|
— |
|
(25,527) |
|
Purchase of property and equipment |
|
(1,060) |
|
(2,973) |
|
Net cash used in investing activities |
|
(1,060) |
|
(28,500) |
|
Cash Flows From Financing Activities: |
|||||
Proceeds from issuance of long-term debt |
|
— |
|
76,850 |
|
Principal payments of long-term debt and finance lease obligations |
(2,110) |
(53,230) |
|||
Payment of contingent consideration |
— |
(2,450) |
|||
Payment of debt issuance costs |
|
(17) |
|
(1,532) |
|
Tax withholdings related to net share settlements of restricted stock |
|
(63) |
|
(100) |
|
Net cash (used in) provided by financing activities |
|
(2,190) |
|
19,538 |
|
Effect of foreign exchange rate changes on cash |
|
973 |
|
(604) |
|
Net increase (decrease) in cash and cash equivalents |
|
11,651 |
|
(387) |
|
Cash and cash equivalents at beginning of period |
|
36,102 |
|
31,901 |
|
Cash and cash equivalents at end of period |
$ |
47,753 |
$ |
31,514 |
ALLIENT INC.
Reconciliation of Non-GAAP Financial Measures
(In thousands, Unaudited)
In addition to reporting revenue and net income, which are
The Company believes that Revenue excluding foreign currency exchange rate impacts is a useful measure in analyzing organic sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not fully under management’s control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period. Organic revenue is reported revenues adjusted for the impact of foreign currency and the revenue contribution from acquisitions.
The Company believes EBITDA and Adjusted EBITDA are often a useful measure of a Company’s operating performance and are a significant basis used by the Company’s management to evaluate and compare the core operating performance of its business from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense, acquisition and integration-related costs, restructuring and business realignment costs, foreign currency gains/losses on short-term assets and liabilities, and other items that are not indicative of the Company’s core operating performance. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP. In addition to the performance measures identified above, we believe that total net debt and leverage ratio provide meaningful measures of liquidity and a useful basis for assessing our ability to fund our activities, including the financing of acquisitions and debt repayments. Total net debt is calculated as total debt less cash and cash equivalents. Leverage ratio is total net debt divided by adjusted EBITDA for the trailing twelve months.
The Company’s calculation of Revenue excluding foreign currency exchange impacts for the three months ended March 31, 2025 is as follows:
Three Months Ended |
|||
March 31, 2025 |
|||
Revenue as reported |
$ |
132,803 |
|
Foreign currency impact |
|
1,819 |
|
Revenue excluding foreign currency exchange impacts |
$ |
134,622 |
The Company’s calculation of organic revenue for the three months ended March 31, 2025 is as follows:
Three Months Ended |
||
March 31, 2025 |
||
Revenue decrease year over year |
(9.4)% |
|
Add: Impact of acquisitions and foreign currency |
|
|
Organic revenue |
(9.1)% |
ALLIENT INC.
Reconciliation of Non-GAAP Financial Measures
(In thousands, Unaudited)
The Company’s calculation of Adjusted EBITDA for the three months ended March 31, 2025 and 2024 is as follows:
Three Months Ended |
||||||
March 31, |
||||||
2025 |
|
2024 |
||||
Net income |
|
$ |
3,557 |
|
$ |
6,902 |
Interest expense |
|
|
3,635 |
|
|
3,388 |
Provision for income tax |
|
|
903 |
|
|
1,919 |
Depreciation and amortization |
|
|
6,281 |
|
|
6,385 |
EBITDA |
|
14,376 |
|
|
18,594 |
|
Stock-based compensation expense |
|
|
920 |
|
|
1,211 |
Acquisition and integration-related costs |
|
|
— |
|
|
326 |
Restructuring and business realignment costs |
|
|
1,499 |
|
|
31 |
Foreign currency loss / (gain) |
|
|
677 |
|
|
(120) |
Adjusted EBITDA |
|
$ |
17,472 |
|
$ |
20,042 |
The Company’s calculation of Total Net Debt and Leverage Ratio as of March 31, 2025 and December 31, 2024 is as follows:
March 31, 2025 |
December 31, 2024 |
||||
Total debt |
$ |
222,202 |
$ |
224,177 |
|
Less: cash and cash equivalents |
$ |
47,753 |
$ |
36,102 |
|
Total net debt (Non-GAAP) |
$ |
174,449 |
$ |
188,075 |
|
TTM Adjusted EBITDA (Non-GAAP) |
$ |
59,955 |
$ |
62,525 |
|
Leverage Ratio (Non-GAAP) |
|
2.91 |
|
3.01 |
ALLIENT INC.
Reconciliation of GAAP Net Income and Diluted Earnings per Share to
Non-GAAP Adjusted Net Income and Adjusted Diluted Earnings per Share
(In thousands, except per share data)
(Unaudited)
The Company’s calculation of Adjusted net income and Adjusted diluted earnings per share for the three months ended March 31, 2025 and 2024 is as follows:
For the three months ended |
||||||||||||
March 31, |
||||||||||||
2025 |
Per diluted
|
2024 |
Per diluted
|
|||||||||
Net income as reported |
$ |
3,557 |
$ |
0.21 |
$ |
6,902 |
$ |
0.42 |
||||
Non-GAAP adjustments, net of tax (1) |
||||||||||||
Amortization of intangible assets - net |
|
2,369 |
|
0.15 |
|
2,463 |
|
0.15 |
||||
Foreign currency loss (gain) - net |
|
519 |
|
0.03 |
|
(92) |
|
(0.01) |
||||
Acquisition and integration-related costs - net |
|
- |
|
- |
|
250 |
|
0.02 |
||||
Restructuring and business realignment costs - net |
|
1,148 |
|
0.07 |
|
23 |
|
- |
||||
Non-GAAP adjusted net income and diluted EPS |
$ |
7,593 |
$ |
0.46 |
$ |
9,546 |
$ |
0.58 |
||||
Weighted average diluted shares outstanding |
|
16,638 |
|
16,272 |
(1) Applies a blended federal, state, and foreign tax rate of |
Adjusted net income and diluted EPS are defined as net income as reported, adjusted for certain items, including amortization of intangible assets and unusual non-recurring items. Adjusted net income and diluted EPS are not a measure determined in accordance with GAAP in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250507892192/en/
Investor Contacts:
Deborah K. Pawlowski / Craig P. Mychajluk
Alliance Advisors IR
716-843-3908 / 716-843-3832
dpawlowski@allianceadvisors.com / cmychajluk@allianceadvisors.com
Source: Allient Inc.